← Back to Search

Lost Wages Reimbursement for Kidney Donors

N/A
Waitlist Available
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
For KT patients: Chronic Kidney Disease (CKD) stage 4/5
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test whether offering to reimburse lost wages will increase the number of people willing to donate kidneys.

Who is the study for?
This trial is for kidney transplant patients approved or on the waiting list, with chronic kidney disease stages 4/5. Their living donors can join if they're in the US and not scheduled for surgery. Excluded are those listed for multiple organs, temporarily unavailable, or in another LDKT study.Check my eligibility
What is being tested?
The study tests if giving money to cover lost wages helps increase live donor kidney transplants. It compares two types of wage reimbursement against standard care without payment.See study design
What are the potential side effects?
Since this trial involves financial compensation rather than medical treatment, there aren't direct physical side effects; however, it may impact participants' stress levels or financial situation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
If you have severe kidney disease (stage 4 or 5).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference between reimbursement arms
Effect of wage reimbursement on racial disparities in LDKT
Effectiveness of wage reimbursement on LDKT rate

Side effects data

From 2016 Phase 4 trial • 8 Patients • NCT01833897
38%
sedation
25%
headache
13%
phosphenes
13%
hypomania
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ketamine and DCS Treatment

Trial Design

2Treatment groups
Experimental Treatment
Group I: LW-BExperimental Treatment2 Interventions
The Lost Wages B (LW-B) arm will be composed of kidney transplant patients meeting the inclusion criteria. This arm allows for possible wage reimbursement of living donor lost wages up to a different amount. This will also include standard of care.
Group II: LW-AExperimental Treatment2 Interventions
The Lost Wages A (LW-A) arm will be composed of kidney transplant patients meeting the inclusion criteria. This arm allows for possible wage reimbursement of living donor lost wages up to a certain amount. This will also include standard of care.

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
835 Previous Clinical Trials
13,006,077 Total Patients Enrolled

Media Library

Wage Reimbursement A Clinical Trial Eligibility Overview. Trial Name: NCT03268850 — N/A
Kidney Disease Research Study Groups: LW-A, LW-B
Kidney Disease Clinical Trial 2023: Wage Reimbursement A Highlights & Side Effects. Trial Name: NCT03268850 — N/A
Wage Reimbursement A 2023 Treatment Timeline for Medical Study. Trial Name: NCT03268850 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment size for this clinical trial?

"Affirmative. According to clinicaltrials.gov, the aforementioned trial is actively searching for participants to participate. The experiment was initially posted on February 5th 2018 and recently modified on June 15th 2021; with a goal of recruiting 735 patients from 1 site."

Answered by AI

Is this research endeavor currently available to enrollees?

"Per clinicaltrials.gov, this trial is actively seeking research subjects and has been since February 5th 2018 when it was first advertised; the details were last amended on June 15th 2021."

Answered by AI
~64 spots leftby Mar 2025